Literature DB >> 14720457

Advances in alcoholic liver disease.

Zhenyuan Song1, Swati Joshi-Barve, Shrish Barve, Craig J McClain.   

Abstract

Cytokines are mediators of cellular communication produced by multiple liver cell types. Cytokines can directly induce either necrosis or apoptosis. They can also recruit such cells as neutrophils and lymphocytes, which can mediate liver damage. Increased levels of hepatotoxic cytokines such as tumor necrosis factor-alpha are documented in alcoholic liver disease (ALD) and nonalcoholic steatohepatitis (NASH) and have been shown to play a mechanistic role in both of these disease processes. Transforming growth factor-beta is a profibrotic cytokine that is critical in hepatic fibrosis. Beneficial cytokines, such as interleukin (IL)-10 and -6, also exist. Such beneficial cytokines as adiponectin are made outside the liver and appear to protect against ALD and NASH. This article reviews the relevance of cytokines in human and experimental forms of liver injury, focusing on modulation of cytokines and the use of beneficial cytokines in treatment and prevention of liver injury in ALD, NASH, and hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14720457     DOI: 10.1007/s11894-004-0029-y

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  47 in total

1.  Interleukin-11 reduces T-cell-dependent experimental liver injury in mice.

Authors:  M Bozza; J L Bliss; R Maylor; J Erickson; L Donnelly; P Bouchard; A J Dorner; W L Trepicchio
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

2.  Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.

Authors:  T Nishikage; S Seki; S Toyabe; T Abo; Y Kagata; T Iwai; H Hiraide
Journal:  J Hepatol       Date:  1999-07       Impact factor: 25.083

3.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

4.  Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.

Authors:  D B Hill; S Barve; S Joshi-Barve; C McClain
Journal:  J Lab Clin Med       Date:  2000-05

5.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

6.  Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor.

Authors:  F Gantner; M Leist; A W Lohse; P G Germann; G Tiegs
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

7.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.

Authors:  Zhaoli Sun; Andrew S Klein; Svetlana Radaeva; Feng Hong; Osama El-Assal; Hong-Na Pan; Barbara Jaruga; Sandor Batkai; Sumito Hoshino; Zhigang Tian; George Kunos; Anna Mae Diehl; Bin Gao
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

9.  Increased plasma interleukin-8 concentrations in alcoholic hepatitis.

Authors:  D B Hill; L S Marsano; C J McClain
Journal:  Hepatology       Date:  1993-09       Impact factor: 17.425

10.  Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression.

Authors:  Ali Canbay; Ariel E Feldstein; Hajime Higuchi; Nate Werneburg; Annette Grambihler; Steve F Bronk; Gregory J Gores
Journal:  Hepatology       Date:  2003-11       Impact factor: 17.425

View more
  5 in total

1.  Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?

Authors:  Haluk Sargin; Mehmet Sargin; Hülya Gozu; Asuman Orcun; Gülcan Baloglu; Murat Ozisik; Mesut Seker; Oya Uygur-Bayramicli
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

2.  Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver.

Authors:  Zhigang Wang; Tong Yao; Zhenyuan Song
Journal:  Alcohol Clin Exp Res       Date:  2009-12-18       Impact factor: 3.455

Review 3.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

4.  Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice.

Authors:  Claudia von Montfort; Juliane I Beier; Luping Guo; J Phillip Kaiser; Gavin E Arteel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-03-06       Impact factor: 4.052

5.  Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4.

Authors:  Amr Ali Hemeda; Amal Ahmad Mohamed; Ramy Karam Aziz; Mohamed S Abdel-Hakeem; Marwa Ali-Tammam
Journal:  Viruses       Date:  2021-04-20       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.